Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On Sitagliptin
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference41 articles.
1. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2. The Glucagon-Like Peptides
3. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide
4. Biological actions and therapeutic potential of the glucagon-like peptides
5. The biology of incretin hormones
Cited by 149 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Miniature mass spectrometer–based point-of-care assay for quantification of metformin and sitagliptin in human blood and urine;Analytical and Bioanalytical Chemistry;2024-04-20
2. Diabetes Technology and Therapy in the Pediatric Age Group;Diabetes Technology & Therapeutics;2023-02-01
3. Development of optimized regression model for Raman spectral analysis of pharmaceutical drugs cefixime and sitagliptin;Journal of Raman Spectroscopy;2022-07-23
4. Evaluation eff ects of IDPP4 therapy diff erent duration on the functional state of α- and β- cells in patients with type 2 diabetes mellitus;Medical Herald of the South of Russia;2022-03-29
5. Evaluation of sitagliptin therapy on the levels of fibroblast growth factor-19 (FGF19) in patients with Type 2 diabetes;Turkish Journal of Internal Medicine;2022-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3